FDA Import Refusal SCS-4304459-8/10002/17 — AAVUGARI SURYA KIRAN
The FDA refused shipment SCS-4304459-8/10002/17 from AAVUGARI SURYA KIRAN (India) on Sep 25, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 25, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,75